Charles David Pauza's most recent trade in Traws Pharma Inc. was a trade of 503,227 Stock Option (right to purchase) done . Disclosure was reported to the exchange on April 1, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Traws Pharma Inc. | Charles David Pauza | Chief Science Officer Virology | 01 Apr 2024 | 503,227 | 503,227 | - | - | Stock Option (right to purchase) | ||
| Traws Pharma Inc. | Charles David Pauza | Chief Science Officer Virology | 01 Apr 2024 | 333,136 | 333,136 | - | - | Stock Option (right to purchase) | ||
| Traws Pharma Inc. | Charles David Pauza | Chief Science Officer Virology | 01 Apr 2024 | 97,500 | 97,500 (0%) | 0% | - | Common Stock |